Winslow Evans & Crocker’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Winslow Evans & Crocker’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-45	Closed	-$2K	–	1180
2020 Q2	$2K	Sell	45 -1	-2%	-$77	﹤0.01%	1069
2020 Q1	$4K	Hold	46	–	–	﹤0.01%	961
2019 Q4	$6K	Buy	+46	New	+$4.12K	﹤0.01%	964
2019 Q2	–	Sell	-42	Closed	-$6K	–	1374
2019 Q1	$6K	Hold	42	–	–	﹤0.01%	973
2018 Q4	$6K	Hold	42	–	–	﹤0.01%	909
2018 Q3	$6K	Buy	42 +26	+163%	+$2.75K	﹤0.01%	930
2018 Q2	$2K	Hold	16	–	–	﹤0.01%	1095
2018 Q1	$986	Buy	+16	New	+$964	﹤0.01%	1064
2017 Q3	–	Sell	-8	Closed	-$969	–	1268
2017 Q2	$969	Buy	+8	New	+$927	﹤0.01%	1211

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Winslow Evans & Crocker's ICPT Position: Q3 2020 in Review

Winslow Evans & Crocker sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2020, closing a stake of 45 shares — an estimated $2K sold.

Winslow Evans & Crocker first reported a position in ICPT in Q2 2017 and held it in 9 quarters. The position peaked at $6K in Q4 2019. 177 funds tracked by Wall St. Rank hold ICPT as of Q3 2020.

Winslow Evans & Crocker reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Winslow Evans & Crocker sold 45 Intercept Pharmaceuticals, Inc. shares in Q3 2020, an estimated $2K.
Winslow Evans & Crocker first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2017 and held it in 9 quarters.
Winslow Evans & Crocker's Intercept Pharmaceuticals, Inc. position peaked at $6K in Q4 2019.
177 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2020.

Based on Winslow Evans & Crocker's 13F filing for Q3 2020, filed 21 Oct 2020.